Provided by Tiger Trade Technology Pte. Ltd.

Atara Biotherapeutics

9.44
+0.42004.66%
Post-market: 9.440.00000.00%19:30 EDT
Volume:20.90K
Turnover:194.93K
Market Cap:94.76M
PE:-7.94
High:9.48
Open:9.08
Low:9.08
Close:9.02
52wk High:19.15
52wk Low:3.92
Shares:10.04M
Float Shares:4.73M
Volume Ratio:0.56
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1889
EPS(LYR):2.57
ROE:-2014.86%
ROA:-24.14%
PB:-2.56
PE(LYR):3.67

Loading ...

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Artivion (AORT) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
May 08

Atara Biotherapeutics jumps 70%, or $3.60, to $8.75

TIPRANKS
·
May 08

Atara Biotherapeutics trading resumes

TIPRANKS
·
May 08

BUZZ-U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise

Reuters
·
May 08

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:50 AM

Reuters
·
May 07

BUZZ-Atara jumps after US FDA backs re-submission of cancer drug application

Reuters
·
May 07

Atara Biotherapeutics Shares Jump 42% After US FDA Backs Resubmission of Co's Cancer Drug Application

THOMSON REUTERS
·
May 07

Atara Biotherapeutics Gains Clearer FDA Path for Tab-cel

TIPRANKS
·
May 07

Why Is Atara Biotherapeutics Stock (ATRA) Up Today?

TIPRANKS
·
May 07

BRIEF-Atara Biotherapeutics Provides Regulatory Update On Tabelecleucel

Reuters
·
May 07

Atara Biotherapeutics Inc - FDA Agrees Single Arm Study May Support Future Tab-Cel Marketing Application

THOMSON REUTERS
·
May 07

Atara Biotherapeutics Inc - Expects Further Tab-Cel Regulatory Update in Third Quarter

THOMSON REUTERS
·
May 07

Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel

THOMSON REUTERS
·
May 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

Atara Biotherapeutics Receives Nasdaq Non-Compliance Delisting Notice

TIPRANKS
·
May 02

Atara Biotherapeutics risks Nasdaq delisting after market value falls below $50 million threshold

Reuters
·
May 02

Atara Biotherapeutics announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 25

Atara Biotherapeutics Faces Securities Lawsuit After FDA Setbacks and Sharp Stock Declines Tied to Tabelecleucel

TIPRANKS
·
Apr 17

Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT), Atara Biotherapeutics (ATRA) and Rezolute (RZLT)

TIPRANKS
·
Mar 30

Atara Biotherapeutics Faces Federal Securities Lawsuit Over Alleged Misstatements About Drug Approval Prospects

TIPRANKS
·
Mar 28